You just read:

FDA Approves INTUNIV(R) (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents

News provided by

Shire plc

Feb 28, 2011, 08:59 ET